- Rheumatoid arthritis is an immune system problem that can reach the heart, lungs, eyes and skin.
- Umbilical cord stem cells are studied to rebalance that immune response rather than switch it off.
- Trials using the cells alongside standard drugs have shown lower inflammation markers and better disease scores.
If you live with rheumatoid arthritis, you know it is not just a joint problem. It shapes your mornings, your energy and your plans, and you want more good days.
Here is what drives it, where today’s medicines leave room for more, and what umbilical cord stem cells are being studied for.
Why is rheumatoid arthritis a whole-body disease?
In rheumatoid arthritis the immune system mistakes the lining of your joints for an enemy. Immune cells move in, release inflammatory messengers such as TNF and IL-6, and the lining thickens and starts eating into cartilage and bone.
Those messengers don’t stay in the joints. They circulate in the blood, which is why rheumatoid arthritis can also affect the heart and blood vessels, the lungs, the eyes and the skin, and why it drains your energy. It is a bit like a neighborhood argument that spills into the whole street.
Where do umbilical cord cells fit next to your medicines?
Methotrexate, biologics and steroids have changed life for a great many people with rheumatoid arthritis. They work by turning down immune activity, and for many that is enough to keep the disease quiet.
For people who want more control of their disease, researchers are studying ways to calm the attack while leaving the rest of the immune system free to do its job. That is where umbilical cord cells come in.
What do stem cells do to the immune system?
Mesenchymal stem cells are natural peacekeepers. In lab studies with cells from patients with rheumatoid arthritis, umbilical cord cells calmed overactive joint-lining cells and T cells and helped expand regulatory T cells, the immune system’s own brakes. In mice with arthritis, infusing the cells lowered inflammatory messengers and eased the disease.
The key word is modulate. The aim is not to switch the immune system off but to help it find its balance again, turning down the part that is attacking you. Think of a mediator at a noisy meeting: nobody gets thrown out, but everyone lowers their voice.
What have trials in people found?
In a Chinese phase I/II study, 64 people with rheumatoid arthritis received umbilical cord stem cells through a vein while continuing their usual medicines. At one and three years, blood markers of inflammation had fallen, disease activity and daily-function scores had improved, and routine safety tests stayed normal.
A 2024 meta-analysis of randomized trials in several kinds of arthritis also points to a potential benefit in rheumatoid arthritis, with a good safety record. Research is growing, and larger controlled trials are building on these results.
- Keep your rheumatologist and your medication at the center of your care.
- If you want more control of your disease, ask for an evaluation of stem cells as an add-on.
- Bring recent labs, including inflammation markers, to any consultation; they show where you are starting from.
The immune-calming effects of umbilical cord stem cells are well documented in the lab and in animal models of arthritis. In people, early-phase trials, mostly from China and used alongside standard drugs, report lower inflammation markers and better disease scores with a good safety record. A meta-analysis of randomized trials points the same way. Research is growing, and umbilical cord cells are a promising add-on to your care.
- The pathogenesis of rheumatoid arthritis · The New England Journal of Medicine, 2011
- Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis · Arthritis Research & Therapy, 2010
- Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study · Drug Design, Development and Therapy, 2019
- Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials · Seminars in Arthritis and Rheumatism, 2024
Questions
Do I stop my medication before the treatment?
No. The protocol works alongside your treatment. Any change to your medication is decided by your rheumatologist.
Will stem cells make my rheumatoid arthritis go away?
The aim is to calm the inflammation driving the disease and help slow its progress; your rheumatologist explains what you can expect in your case.
Who can’t have the intravenous protocol?
Every intravenous protocol starts with blood work and cancer markers on day one, for your safety. Your rheumatologist reviews the rest of your case with you.
What should I send for the evaluation?
Your diagnosis, your current medication and your most recent labs, especially inflammation markers such as ESR and CRP.